Is INTENSITY THERAPEUTICS, INC. (INTS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.7% / 30% | 12.9% / 30% | 0.0% / 30% | N/A | ✓ HALAL |
| DJIM | 0.7% / 33% | 12.9% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| MSCI | 2.9% / 33% | 54.2% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 0.7% / 33% | 12.9% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| FTSE | 2.9% / 33% | 54.2% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -234.7% | |
| Return on Assets (ROA) | -101.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$15M |
| Free Cash Flow | -$15M |
| Total Debt | $138,000 |
| Debt-to-Equity | 1.6 |
| Current Ratio | 3.6 |
| Total Assets | $5M |
Price & Trading
| Last Close | $6.10 |
| 50-Day MA | $7.88 |
| 200-Day MA | $8.49 |
| Avg Volume | 57K |
| Beta | 4.3 |
|
52-Week Range
$4.62
| |
About INTENSITY THERAPEUTICS, INC. (INTS)
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is INTENSITY THERAPEUTICS, INC. (INTS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), INTENSITY THERAPEUTICS, INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is INTENSITY THERAPEUTICS, INC.'s debt ratio?
INTENSITY THERAPEUTICS, INC.'s debt ratio is 0.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 2.9%.
What are INTENSITY THERAPEUTICS, INC.'s key financial metrics?
INTENSITY THERAPEUTICS, INC. has a market capitalization of $15M. Return on equity stands at -234.7%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.